Lululemon reports flat US sales for its third financial quarter. Piper Sandler expects a weak 2025 for Lululemon stock.
Piper Sandler raised the firm’s price target on Asana (ASAN) to $19 from $12 and keeps a Neutral rating on the shares following Q3 results. The firm noted that Asana continues to operate in a ...
Piper Sandler analyst Anna Andreeva maintained a Hold rating on Lululemon Athletica (LULU – Research Report) today and set a price target of ...
Samsara slipped during early market action Friday after its Q3 fiscal 2025 financial results topped estimates but failed to ...
Fintel reports that on December 5, 2024, Piper Sandler downgraded their outlook for nCino (NasdaqGS:NCNO) from Overweight to ...
Cino (NASDAQ:NCNO) stock dropped 12% in late Thursday trading after the company issued weak guidance for Q4 revenue late ...
Piper Sandler raised the firm’s price target on Teladoc (TDOC) to $13 from $11 and keeps an Overweight rating on the shares ...
Piper Sandler raised the firm’s price target on Okta (OKTA) to $90 from $85 and keeps a Neutral rating on the shares. A ...
周五,Piper Sandler对GitLab Inc (NASDAQ: GTLB)表示信心,将其目标价从75.00美元上调至85.00美元,同时维持对该股的"增持"评级。GitLab股票目前交易价格为66.04美元,分析师给出的目标价范围从55美元到90美元不等,在1代表"强烈买入"的评级体系中,GitLab获得了1.5的强烈共识推荐。
Piper Sandler analyst David Amsellem reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report) today and set a price target of ...
Investing.com -- Investors should temper their expectations regarding the potential accomplishments of the Department of ...
此次调整是在Samsara公布第三财季业绩后做出的,该业绩与分析师的预测一致,并超过了普遍预期。根据InvestingPro数据,该股票今年以来表现强劲,年初至今回报率达65%,尽管目前交易价格高于其计算的公允价值。